A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca2+ Signaling Pathway

Jingyun Liu(Second Affiliated Hospital of Xi'an Jiaotong University), Haiying Ma(Dalian Medical University)
Pharmaceuticals
November 28, 2022
Cited by 7


Related Papers